<script type="application/ld+json">
{
    "@context": "http://schema.org",
    "@type": "MedicalWebPage",
    "publisher": {
        "@type": "Organization",
        "name": "Eli Lilly and Company India",
        "legalName": "Eli Lilly and Company (India) Pvt. Ltd.",
        "description": "Eli Lilly and Company in India, Sri Lanka, Nepal, and Bangladesh",
        "url": "https://www.lillyindia.co.in/",
        "logo": "https://www.lillyindia.co.in/_Global-Assets/img/lilly_logo.png",
        "sameAs": [
            "https://twitter.com/LillyPad/",
            "https://www.facebook.com/elilillyandco/",
            "https://www.instagram.com/elilillyco/",
            "https://www.linkedin.com/company/eli-lilly-and-company/",
            "https://www.youtube.com/user/EliLillyandCompany/"
        ],
    "alternateName":"Lilly India"
    },
    "about": {
        "@type": "Drug",
        "name": "Cyramza",
        "nonProprietaryName": "ramucirumab",
        "pregnancyCategory": "http://health-lifesci.schema.org/FDAcategoryC",
        "pregnancyWarning": "Risk cannot be ruled out",
        "prescriptionStatus": "http://health-lifesci.schema.org/PrescriptionOnly"
    },
    "name": "Cyramza",
    "audience": "Patient",
    "description": "CyramzaÂ® (Ramucirumab) is used with other medications for the treatment of patients with lung, stomach, and colorectal tumors after prior chemotherapy treatment.",
    "lastReviewed": "2017-24-25",
    "dateModified": "2017-04-25"
}
</script>